These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6335330)

  • 1. [Rheumatic diseases with skin manifestations: connective tissue metabolism and immune mechanisms (basic research and clinical aspects). Vienna, 26-28 April 1984. Symposium].
    Z Rheumatol; 1984; 43 Suppl 1():1-55. PubMed ID: 6335330
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symposium: Etiology of rheumatic diseases. 6. From the standpoint of metabolism of the connecting tissue--with special reference to intercellular matrix-composing proteoglycans].
    Murata K
    Ryumachi; 1973 Oct; 13(4):359-62. PubMed ID: 4278918
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous manifestations of selected rheumatologic diseases.
    Ostezan LB; Callen JP
    Am Fam Physician; 1996 Apr; 53(5):1625-36. PubMed ID: 8623690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism of the connective tissue in generalized scleroderma].
    Kucharz EJ; Sierakowski SJ
    Postepy Hig Med Dosw; 1989; 43(1):93-102. PubMed ID: 2697876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin disorders associated with rheumatic disease.
    Kaminski MJ
    Clin Podiatr Med Surg; 1996 Jan; 13(1):139-53. PubMed ID: 8849938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Connective tissue metabolites in tissue fluids. New possibilities for monitoring the fibrotic process].
    Bentsen KD; Hørslev-Petersen K; Junker P
    Ugeskr Laeger; 1986 Aug; 148(32):2007-11. PubMed ID: 3529559
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dermal changes in rheumatic diseases].
    Kreysel HW; Kimmig J
    Internist (Berl); 1974 Jun; 15(6):304-11. PubMed ID: 4603062
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatic symptoms and cholesterol deposits.
    Bland JH
    N Engl J Med; 1970 Jul; 283(5):263. PubMed ID: 5310498
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary manifestations of rheumatic diseases.
    Eid NS; Buchino JJ; Schikler KN
    Pediatr Pulmonol Suppl; 1999; 18():91-2. PubMed ID: 10093108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatologic manifestations of rheumatic disorders.
    McCauliffe DP; Sontheimer RD
    Prim Care; 1993 Dec; 20(4):925-41. PubMed ID: 8310089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics.
    Sontheimer RD
    Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):429-62. PubMed ID: 15158749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibronectin in plasma and synovial fluid from patients with rheumatic diseases].
    Matsumoto Y; Imaizumi T; Kanie R
    Ryumachi; 1986 Aug; 26(4):252-8. PubMed ID: 3494315
    [No Abstract]   [Full Text] [Related]  

  • 13. D-penicillamine effects on inflammatory and normal connective tissues in rats. Studies on collagen, glycosaminoglycans and nucleic acids with particular reference to antirheumatoid therapy.
    Junker P
    Dan Med Bull; 1985 May; 32(2):87-103. PubMed ID: 2408821
    [No Abstract]   [Full Text] [Related]  

  • 14. [Various aspects of the pathogenesis of systemic scleroderma and the role of microcirculation in the morphogenesis of joint changes in the diseases].
    Rusakova MS
    Vopr Revm; 1982; (2):68-71. PubMed ID: 7113091
    [No Abstract]   [Full Text] [Related]  

  • 15. [The molecular level of pathological processes in connective tissue in rheumatism].
    Tustanovskiĭ AA
    Vopr Revm; 1969; 9(2):7-13. PubMed ID: 5308156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathologic changes of the skin in rheumatic diseases].
    Rácz I
    Z Rheumaforsch; 1967 Jun; 26(5):201-13. PubMed ID: 5302981
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cutaneous manifestations in rheumatic diseases].
    Kaneko F; Orikasa R; Ohtsuka M; Furukawa H
    Ryumachi; 1996 Aug; 36(4):676-87. PubMed ID: 8911087
    [No Abstract]   [Full Text] [Related]  

  • 18. The excretion of nondialyzable urinary mucopolysaccharide in rheumatic and other systemic disease states.
    Thompson GR; Castor CW
    J Lab Clin Med; 1966 Oct; 68(4):617-27. PubMed ID: 4224250
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphology and pathogenesis of soft-tissue rheumatism].
    Fassbender HG; Wegner K
    Z Rheumaforsch; 1973; 32(9):355-74. PubMed ID: 4544013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of the molecular hyperaggregation of the collagen by means of sulfhydryl compounds].
    Rovetta G; Ghirardo G
    Reumatismo; 1971; 23(4):211-6. PubMed ID: 5317289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.